Search filters

List of works by Wendy K. Nevala

A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG Study

scientific article published on December 2008

A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma

scientific article

A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1

scientific article published on 01 August 2019

A reproducible method for the enumeration of functional (cytokine producing) versus non-functional peptide-specific cytotoxic T lymphocytes in human peripheral blood

scientific article published on 01 September 2006

An organ system based approach to prognosis in advanced melanoma

scientific article published on 01 June 2012

Antibody-Targeted Chemotherapy for the Treatment of Melanoma

scientific article

Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20+ B-cell lymphoma

scientific article published on 05 April 2017

Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue

scientific article

CD206-positive myeloid cells bind galectin-9 and promote a tumor-supportive microenvironment.

scientific article published on 7 May 2018

Cloned Cattle Can Be Healthy and Normal

scientific article published on November 30, 2001

Contraction of T cell richness in lung cancer brain metastases.

scientific article published in February 2018

Correction: Antibody-Targeted Chemotherapy for the Treatment of Melanoma

scientific article published on 01 September 2019

Differential Response of Human and Mouse Dendritic Cells to VEGF Determines Interspecies Discrepancies in Tumor-Mediated Th1/Th2 Polarity Shift

scientific article published on February 24, 2011

Effect of the lymphocyte-to-monocyte ratio on the clinical outcome of chemotherapy administration in advanced melanoma patients

scientific article published on 7 November 2016

Endogenous Heat-Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma.

scientific article

Evidence of Th2 polarization of the sentinel lymph node (SLN) in melanoma.

scientific article

Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma

scientific article published on 24 February 2009

Expansion of CD16-Negative Natural Killer Cells in the Peripheral Blood of Patients with Metastatic Melanoma

scientific article published on February 23, 2011

Fetal sex-based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum period.

scientific article

Fluctuation of systemic immunity in melanoma and implications for timing of therapy

scientific article published on January 1, 2012

GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts

scientific article published on 21 November 2018

Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma.

scientific article published on 22 July 2016

Growth modeling of the maternal cytokine milieu throughout normal pregnancy: macrophage-derived chemokine decreases as inflammation/counterregulation increases

scientific article

H4 and CTT-2 minor histocompatibility antigens: concordant genetic linkage and migration in two-dimensional peptide separation

scientific article published on 01 January 1996

Human Melanoma-Derived Extracellular Vesicles Regulate Dendritic Cell Maturation

scientific article

Identification of a peptide-peptide binding motif in the coating of nab-paclitaxel nanoparticles with clinical antibodies: bevacizumab, rituximab, and trastuzumab

scientific article published on 3 November 2017

Identification of mimotopes for the H4 minor histocompatibility antigen

scientific article published on April 1, 1998

Identification of novel, immune-mediating extracellular vesicles in human lymphatic effluent draining primary cutaneous melanoma

scientific article published on 30 September 2019

Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics

scientific article

Immunodominant minor histocompatibility antigen peptides presented by H2Db molecules

scientific article published on 01 November 1997

Immunodominant minor histocompatibility antigen peptides recognized by cytolytic T lymphocytes primed by indirect presentation

scientific article published on February 27, 1998

Immunologic Autograft Engineering and Survival in Non-Hodgkin Lymphoma

scientific article published on 27 January 2016

Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma

scientific article

Leukemic Extracellular Vesicles Induce Chimeric Antigen Receptor T Cell Dysfunction in Chronic Lymphocytic Leukemia

scientific article published on 31 December 2020

Neoantigenic potential of complex chromosomal rearrangements in mesothelioma

scientific article published on 10 October 2018

Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot study

scientific article published on 13 July 2018

Normal ageing is associated with an increase in Th2 cells, MCP-1 (CCL1) and RANTES (CCL5), with differences in sCD40L and PDGF-AA between sexes

scientific article published in November 2012

Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization

scientific article

Peptide vaccine with glucopyranosyl lipid A-stable oil-in-water emulsion for patients with resected melanoma

scientific article published on 05 August 2020

Personalized Therapy for Metastatic Melanoma: Could Timing Be Everything?

scientific article published on November 1, 2012

Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675.

scientific article

Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma

scientific article

Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine

scientific article published on 01 October 2011

Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation

scientific article published on 01 November 2020

Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo

scientific article published on 01 February 1997

T cell Bim levels reflect responses to anti-PD-1 cancer therapy.

scientific article published on May 2016

The dynamic human immune response to cancer: it might just be rocket science

article by Shernan G Holtan et al published 1 September 2011 in Immunotherapy

The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma.

scientific article published on May 2013

The preferential cytolytic T lymphocyte response to immunodominant minor histocompatibility antigen peptides

scientific article published on 01 July 1996

Understanding heterogeneous tumor microenvironment in metastatic melanoma

scientific article published on 05 June 2019

Untreated stage IV melanoma patients exhibit abnormal monocyte phenotypes and decreased functional capacity

scientific article published on 18 November 2013

Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions

scientific article